Teva Pharma receives European marketing approvals for Ponlimsi, biosimilar to Prolia and Degevma, biosimilar to Xgeva: Tel Aviv, Israel Thursday, November 27, 2025, 11:00 Hrs [IST ...
WHO releases new framework to tackle drug resistance to HIV, hepatitis B and C, and STIs: Geneva Thursday, November 27, 2025, 10:00 Hrs [IST] The World Health Organization (WHO) h ...
AstraZeneca’s Imfinzi approved in US as first and only perioperative immunotherapy for patients with early gastric and GEJ cancers: Cambridge, UK Thursday, November 27, 2025, 09 ...
The Karnataka Food and Drugs Administration (FDA) has reaffirmed its uncompromising stance against Not-of-Standard-Quality (NSQ) drugs, declaring that there is absolutely no room for tolerating such ...
The Drugs Consultative Committee (DCC), the advisory committee that advises the Central and State Governments on matters that require uniform implementation of drug laws across the country, has ...
DCC stresses on need for uniform implementation of drug standards nationwide: Gireesh Babu, New Delhi Thursday, November 27, 2025, 08:00 Hrs [IST] Alarmed by various issues includ ...
The Indian Council of Medical Research (ICMR) has released eighth detailed report from the ICMR AMR surveillance network. ICMR has been supporting the Antimicrobial Resistance Research & Surveillance ...
Punjab bars pharmacists from administering injections as IPA pushes national vaccinator training: Peethaambaran Kunnathoor, Chennai Thursday, November 27, 2025, 08:00 Hrs [IST] Th ...
Reuse of single-use medical devices takes center stage at 2025 Medicine & Law Convention, call for India specific regulations: Our Bureau, Bengaluru Wednesday, November 26, 2025, ...
Arth by Emcure launches “Invest in Iron” campaign with MS Dhoni on World Iron Deficiency Day: Our Bureau, Mumbai Wednesday, November 26, 2025, 17:40 Hrs [IST] Arth by Emcure, ...
Otsuka submits NDA for centanafadine with US FDA to treat ADHD in children, adolescents and adults: Princeton, New Jersey Wednesday, November 26, 2025, 18:00 Hrs [IST] Otsuka Phar ...
Zydus & RK Pharma ink exclusive licensing and commercialization agreement for novel 505(b)(2) product of supportive oncology treatment for USA market: Our Bureau, Mumbai Wednesday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results